Biosynthesis and signalling functions of central and peripheral nervous system neurosteroids in health and disease. Issue 3 (5th August 2020)

• Record Type: Journal Article
• Authors: Lloyd-Evans, Emyr; Waller-Evans, Helen
• Editors: Harwood, John; Lloyd-Evans, Emyr
• Is Part Of: Essays in biochemistry. Volume 64:Issue 3(2020)
• Page Start: 591
• Page End: 606
• Publication Date: 2020-08-05
• Subjects: Alzheimers disease -- GABA -- glutamate receptor -- multiple sclerosis -- Neurosteroid -- Niemann Pick type C; Biochemistry -- Periodicals; 572
• DOI: 10.1042/EBC20200043
• Languages: English
• ISSNs: 0071-1365

Abstract

Abstract: Neurosteroids are steroid hormones synthesised de novo in the brain and peripheral nervous tissues. In contrast to adrenal steroid hormones that act on intracellular nuclear receptors, neurosteroids directly modulate plasma membrane ion channels and regulate intracellular signalling. This review provides an overview of the work that led to the discovery of neurosteroids, our current understanding of their intracellular biosynthetic machinery, and their roles in regulating the development and function of nervous tissue. Neurosteroids mediate signalling in the brain via multiple mechanisms. Here, we describe in detail their effects on GABA (inhibitory) and NMDA (excitatory) receptors, two signalling pathways of opposing function. Furthermore, emerging evidence points to altered neurosteroid function and signalling in neurological disease. This review focuses on neurodegenerative diseases associated with altered neurosteroid metabolism, mainly Niemann-Pick type C, multiple sclerosis and Alzheimer disease. Finally, we summarise the use of natural and synthetic neurosteroids as current and emerging therapeutics alongside their potential use as disease biomarkers.